Search

for
Search:

Sort by

Research

30 / 1000+ results

Ruxolitinib Reverses Alopecia Areata Via a Triple Mechanism: JAK-STAT Inhibition, Localized Oxidative Stress Attenuation and Selective Apoptosis Modulation

research Ruxolitinib reverses alopecia areata via a triple mechanism: JAK-STAT inhibition, localized oxidative stress attenuation and selective apoptosis modulation

March 2026 in “Journal of Translational Autoimmunity”

This study investigates the mechanisms by which ruxolitinib, a JAK inhibitor, reverses alopecia areata (AA) in a C3H/HeJ mouse model. Over 98 days, ruxolitinib treatment led to significant hair regrowth by day 85, reduced inflammatory cytokines, decreased T-cell infiltration, and lowered STAT phosphorylation. It also attenuated local oxidative stress and keratinocyte apoptosis without affecting autophagy or systemic oxidative markers. The study concludes that ruxolitinib's efficacy in treating AA is due to a triple mechanism: inhibition of the JAK-STAT pathway, reduction of local oxidative stress and apoptosis, and disruption of the inflammatory cycle, supporting the potential for targeted topical therapies.

research Pharmacologic inhibition of JAK-STAT signaling promotes hair growth

159 citations , October 2015 in “Science Advances”

Blocking JAK-STAT signaling can lead to hair growth.

research Inhibition of JAK-STAT Signaling with Baricitinib Reduces Inflammation and Improves Cellular Homeostasis in Progeria Cells

51 citations , October 2019 in “Cells”

Baricitinib reduces inflammation and improves cell health in premature aging cells.

research An overview of JAK/STAT pathways and JAK inhibition in alopecia areata

40 citations , August 2022 in “Frontiers in immunology”

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

research Mesenchymal Stem Cells Antagonize IFN-Induced Proinflammatory Changes and Growth Inhibition Effects via Wnt/β-Catenin and JAK/STAT Pathway in Human Outer Root Sheath Cells and Hair Follicles

14 citations , April 2021 in “International journal of molecular sciences”

Mesenchymal stem cells may help treat hair loss by improving hair cell growth and reducing inflammation.

research APECED: JAK Inhibition in an Adult Case with Long-Term Follow-up

December 2025 in “Journal of Human Immunity”

JAK inhibitors may help improve symptoms in adults with APECED.

research Alopecia Universalis Treated With Tofacitinib: The Role of JAK/STAT Inhibitors in Hair Regrowth

November 2023 in “Cutis”

Tofacitinib helped a woman with total-body hair loss grow her hair back.

research Efficacy of JAK 1/2 inhibition in the treatment of diffuse non-scarring alopecia due to systemic lupus erythematosus

16 citations , January 2020 in “Annals of the rheumatic diseases”

Baricitinib might help treat hair loss in lupus patients, but more research is needed.

Janus Kinase Inhibition in Down Syndrome: Two Cases of Therapeutic Benefit for Alopecia Areata

research Janus kinase inhibition in Down syndrome: 2 cases of therapeutic benefit for alopecia areata

32 citations , April 2019 in “JAAD case reports”

JAK inhibitors helped treat hair loss in two people with Down syndrome.

research Unexpected Hair Regrowth in a Patient with Longstanding Alopecia Universalis During Treatment of Recalcitrant Dermatomyositis with the Janus Kinase Inhibitor Ruxolitinib

13 citations , January 2020 in “Acta Dermato Venereologica”

Ruxolitinib treatment led to unexpected hair regrowth in a patient with alopecia universalis.

research Topical JAK Inhibitors for the Treatment of Alopecia Areata and Vitiligo

March 2017 in “Current dermatology reports”

Topical JAK inhibitors can effectively treat alopecia areata and vitiligo by modulating immune responses.

research Hair Growth Effect of Emulsion Extracted Brevilin A, a JAK3 Inhibitor, from Centipeda minima

15 citations , June 2020 in “Processes”

CMX from Centipeda minima can significantly improve hair growth in mild to moderate balding.

research 681 Inhibition of STAT3, using Oenocarpus bataua vegetable oil, on in vitro model

April 2016 in “Journal of Investigative Dermatology”

Oenocarpus bataua vegetable oil may help reduce hair loss by affecting a key gene pathway.

research Under Development JAK Inhibitors for Dermatologic Diseases

14 citations , January 2020 in “Mediterranean Journal of Rheumatology”

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

research Considerations for the Treatment Strategy of Relapse After Tofacitinib Therapy in Alopecia Areata

July 2025 in “Journal of Cosmetic Dermatology”

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

research Small Molecule Inhibitors and Inflammatory Skin Diseases

March 2018 in “Suez Canal University Medical Journal”

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

research Alopecia universalis successfully treated with tofacitinib

2 citations , May 2017 in “Journal of the American Academy of Dermatology”

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

research Unexpected Effect of Baricitinib Use: Observation of a Case of Hypertrichosis

March 2026 in “Indian Journal of Dermatology”

Baricitinib can cause excessive hair growth.

research Alopecia universalis with IL-12-RB1 and STAT4 mutations effectively treated with upadacitinib

August 2024 in “JAAD Case Reports”

Upadacitinib successfully regrew hair in a child with alopecia universalis and specific genetic mutations.

research Good efficacy achieved by baricitinib in the treatment of anti-MDA5 antibody-positive dermatomyositis with alopecia areata

3 citations , February 2022 in “Rheumatology”

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

research Concomitant management of alopecia universalis and ulcerative colitis with upadacitinib

2 citations , September 2024 in “Internal Medicine Journal”

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

Topical Ruxolitinib in Combination with Oral Minoxidil Results in Hair Regrowth in a Patient with Central Centrifugal Cicatricial Alopecia and Concomitant Traction Alopecia

research Topical Ruxolitinib in Combination with Oral Minoxidil Results in Hair Regrowth in a Patient with Central Centrifugal Cicatricial Alopecia and Concomitant Traction Alopecia

April 2025 in “JAAD Case Reports”

Topical ruxolitinib and oral minoxidil together can regrow hair in certain types of hair loss.

research Montagna Symposium 2017—Precision Dermatology: Next Generation Prevention, Diagnosis, and Treatment

1 citations , May 2018 in “The journal of investigative dermatology/Journal of investigative dermatology”

The symposium highlighted the importance of understanding disease mechanisms for targeted dermatology treatments.

Unexpected Extensive Hair Whitening Following Baricitinib Treatment for Alopecia Universalis: A Case Report and Mechanistic Insights

research Unexpected Extensive Hair Whitening Following Baricitinib Treatment for Alopecia Universalis: A Case Report and Mechanistic Insights

December 2024 in “Cureus”

Baricitinib treatment for alopecia universalis can cause hair regrowth with unexpected whitening.

Hair Follicle Stem Cells and the Collapse of Self-Tolerance in Alopecia: The Interplay of Barrier Function, the Microbiome, and Immunity

research Hair follicle stem cells and the collapse of self-tolerance in alopecia: the interplay of barrier function, the microbiome, and immunity

November 2024 in “EMBO Molecular Medicine”

JAK inhibitors may reverse early hair loss, but prolonged inflammation can cause permanent hair loss.

Tofacitinib Treatment of Inflammatory Skin Conditions in Patients With Down Syndrome

research SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation

26 citations , June 2024 in “Frontiers in Immunology”

SOCS1 and SOCS3 help control skin inflammation and are important for developing treatments for skin diseases.